Mastrofrancesco, A <br/><br/>
Pharmacological PPARγ modulation regulates sebogenesis and inflammation in SZ95 human sebocytes.  [electronic resource] 

 -  Biochemical pharmacology  08 2017 
 - 96-106 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-2968 
<br/><br/><label>Standard No.: </label>10.1016/j.bcp.2017.04.030  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetanilides--adverse effects<br/>Anilides--adverse effects<br/>Anti-Inflammatory Agents, Non-Steroidal--adverse effects<br/>Cell Cycle--drug effects<br/>Cell Line<br/>Cell Proliferation--drug effects<br/>Cell Survival--drug effects<br/>Cytokines--agonists<br/>Dermatologic Agents--adverse effects<br/>Gene Expression Regulation--drug effects<br/>Humans<br/>Hypoglycemic Agents--antagonists & inhibitors<br/>Insulin--pharmacology<br/>Insulin Antagonists--adverse effects<br/>Lipogenesis--drug effects<br/>Lipopolysaccharides--antagonists & inhibitors<br/>PPAR gamma--agonists<br/>Phenylpropionates--adverse effects<br/>RNA Interference<br/>Sebaceous Glands--cytology<br/>Sebum--drug effects<br/>Signal Transduction--drug effects